Risks of long-acting beta-agonists in achieving asthma control

N Engl J Med. 2009 Apr 16;360(16):1671-2. doi: 10.1056/NEJMe0902057.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Agonists / adverse effects
  • Adrenergic beta-Agonists / therapeutic use*
  • Asthma / drug therapy*
  • Bronchodilator Agents / adverse effects
  • Bronchodilator Agents / therapeutic use
  • Humans
  • Risk Assessment

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents